Novel Approaches To Quantifying Cardioprotective Medication Use in High-Risk Kidney Transplant Recipients

被引：0
|
作者：
Lentine, Krista [1 ]
Xiao, Huiling [1 ]
Schnitzler, Mark [1 ]
Abbott, Kevin
Salvalaggio, Paolo [2 ]
Axelrod, David
Brennan, Daniel [3 ]
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Washington Univ, St Louis, MO 63130 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [41] Selective cellcept therapy in high-risk renal transplant recipients
    Isenberg, A
    Singh, TP
    Shen, GK
    Freed, BM
    Conti, DJ
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1188 - 1189
  • [42] SPLENECTOMY IN HIGH-RISK PRIMARY RENAL-TRANSPLANT RECIPIENTS
    OKIYE, SE
    ZINCKE, H
    ENGEN, DE
    STERIOFF, S
    OFFORD, KP
    FROHNERT, PP
    JOHNSON, WJ
    AMERICAN JOURNAL OF SURGERY, 1983, 146 (05): : 594 - 601
  • [43] FLUCONAZOLE PROPHYLAXIS FOR HIGH-RISK LIVER-TRANSPLANT RECIPIENTS
    KUNG, N
    FISHER, N
    GUNSON, B
    HASTINGS, M
    MUTIMER, D
    LANCET, 1995, 345 (8959): : 1234 - 1235
  • [44] Letermovir for cytomegalovirus prophylaxis in high-risk heart transplant recipients
    Golob, Stephanie
    Batra, Jaya
    DeFilippis, Ersilia M.
    Uriel, Matan
    Carey, Matt
    Gaine, Maureen
    Mabasa, Angelo
    Fried, Justin
    Raikelkar, Jayant
    Restaino, Susan
    Lee, Sun Hi
    Latif, Farhana
    Yuzefpolskaya, Melana
    Colombo, Paolo C.
    Choe, Jason
    Majure, David
    Jennings, Douglas
    Pereira, Marcus R.
    Clerkin, Kevin
    Sayer, Gabriel
    Uriel, Nir
    CLINICAL TRANSPLANTATION, 2022, 36 (12)
  • [45] Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients
    Villanego, Florentino
    Mazuecos, Auxiliadora
    Cubillo, Beatriz
    Jose Merino, M.
    Poveda, Inmaculada
    Saura, Isabel M.
    Segurado, Oscar
    Cruzado, Leonidas
    Eady, Myriam
    Zarraga, Sofia
    Jose Aladren, M.
    Cabello, Sheila
    Lopez, Veronica
    Gonzalez, Esther
    Lorenzo, Inmaculada
    Espi-Reig, Jordi
    Fernandez, Constantino
    Osma, July
    Ruiz-Fuentes, M. Carmen
    Toapanta, Nestor
    Franco, Antonio
    Burballa, Carla C.
    Munoz, Miguel A.
    Crespo, Marta
    Pascual, Julio
    CLINICAL KIDNEY JOURNAL, 2022, 15 (10) : 1847 - 1855
  • [46] CYCLOSPORINE VERSUS AZATHIOPRINE IN HIGH-RISK CADAVER KIDNEY-TRANSPLANT RECIPIENTS - A PROSPECTIVE RANDOMIZED STUDY
    NORMAN, DJ
    WETZSTEON, P
    BARRY, JM
    BENNETT, WM
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1845 - 1845
  • [47] Renal Outcomes of High-Risk Kidney Transplant Recipients After Conversion to Belatacept-Based Immunosuppression
    Anders, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S847 - S848
  • [48] Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial
    不详
    TRANSPLANTATION, 2023, 107 (12) : 2448 - 2448
  • [49] Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients.
    Lacha, J
    Simova, M
    Noskova, L
    Teplan, V
    Vitko, S
    TRANSPLANTATION, 2000, 69 (08) : S158 - S158
  • [50] Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients A Randomized Clinical Trial
    Limaye, Ajit P.
    Budde, Klemens
    Humar, Atul
    Vincenti, Flavio
    Kuypers, Dirk R. J.
    Carroll, Robert P.
    Stauffer, Nicole
    Murata, Yoshihiko
    Strizki, Julie M.
    Teal, Valerie L.
    Gilbert, Christopher L.
    Haber, Barbara A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (01): : 33 - 42
12345